Bradsaúde (SAUD3) Q2 2026 earnings summary

Executive summary

• Achieved 13.6 million beneficiaries, with 99,000 net additions in health and 130,000 in dental in 2Q26; SME segment surpassed 3 million beneficiaries.

• Revenue grew 10.8% year-over-year to R$13.9 billion in 2Q26; net income rose 24.8% to R$1.1 billion.

• ROE/ROAE increased by four percentage points to 25.8%.

• Atlântica Hospitais net income surged 312% year-over-year to R$64 million, now representing 6% of consolidated results.

• Corporate reorganization completed in May 2026, consolidating healthcare businesses under Bradsaúde S.A.

Financial highlights

• Consolidated revenue for the last 12 months reached BRL 54 billion, up from BRL 52 billion at the end of February.

• Net income for 1H26 was R$2.4 billion (+27.6% YoY); consolidated net income for the last 12 months was BRL 4.2 billion.

• Bradesco Saúde premiums grew at an average annual rate of over 12% since 2022, reaching BRL 13 billion.

• Odontoprev revenue reached BRL 2.5 billion, with net margin over 20% per year.

• Financial assets reached R$29.6 billion (+8.7% YoY).

Outlook and guidance

• Expectation of continued stable loss ratio for the year, with some seasonality in Q3 but overall relative stability.

• Growth strategy focuses on disciplined underwriting, SME segment expansion, and new product launches.

• Expansion in hospital network and continued focus on SME and corporate segments expected to drive future growth.

• Atlântica Hospitais expected to increase its share of consolidated results to over 10% in 5-7 years.

• Continued expansion in hospital bed capacity projected through 2030.